Scleroderma autoantibodies in guiding monitoring and treatment decisions
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Scleroderma autoantibodies in guiding monitoring and treatment decisions
Authors
Keywords
-
Journal
CURRENT OPINION IN RHEUMATOLOGY
Volume 34, Issue 6, Pages 302-310
Publisher
Ovid Technologies (Wolters Kluwer Health)
Online
2022-09-09
DOI
10.1097/bor.0000000000000904
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Anti-Ro52 Autoantibody Is Common in Systemic Autoimmune Rheumatic Diseases and Correlating with Worse Outcome when Associated with interstitial lung disease in Systemic Sclerosis and Autoimmune Myositis
- (2022) Edward K. L. Chan CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY
- Three Cases of Systemic Sclerosis Within One Family With Different Antibodies and Clinical Features
- (2022) Julia Spierings et al. JOURNAL OF RHEUMATOLOGY
- Autoantibody profiles associated with morbidity and mortality in scleroderma renal crisis
- (2022) Hideaki Tsuji et al. RHEUMATOLOGY
- Over one‐third of Th/To antibody positive scleroderma patients develop pulmonary hypertension in long‐term follow‐up
- (2022) Shashank Suresh et al. Arthritis & Rheumatology
- False positive anti-Topoisomerase I (Scl-70) antibody results in clinical practice: A case series from a scleroderma referral center
- (2022) Brian H. Lam et al. SEMINARS IN ARTHRITIS AND RHEUMATISM
- PM-Scl and Th/To in systemic sclerosis: a comparison of different autoantibody assays
- (2021) C. A. Mecoli et al. CLINICAL RHEUMATOLOGY
- The clinical phenotype of Systemic Sclerosis patients with anti-PM/Scl antibodies: results from the EUSTAR cohort
- (2021) Maria-Grazia Lazzaroni et al. RHEUMATOLOGY
- Tocilizumab Prevents Progression of Early Systemic Sclerosis Associated Interstitial Lung Disease
- (2021) David Roofeh et al. Arthritis & Rheumatology
- Comprehensive analysis of the major histocompatibility complex in systemic sclerosis identifies differential HLA associations by clinical and serological subtypes
- (2021) Marialbert Acosta-Herrera et al. ANNALS OF THE RHEUMATIC DISEASES
- Autoantibody profiles in systemic sclerosis; a comparison of diagnostic tests
- (2021) Wynand Alkema et al. AUTOIMMUNITY
- Anti–Polymyositis/Scl Antibodies in Systemic Sclerosis
- (2021) Nerea Iniesta Arandia et al. JCR-JOURNAL OF CLINICAL RHEUMATOLOGY
- Anti-RNPC-3 antibody predicts poor prognosis in patients with interstitial lung disease associated to systemic sclerosis
- (2021) Eduardo Luis Callejas-Moraga et al. RHEUMATOLOGY
- Molecular basis for clinical diversity between autoantibody subsets in diffuse cutaneous systemic sclerosis
- (2021) Kristina Elizabeth Neergaard Clark et al. ANNALS OF THE RHEUMATIC DISEASES
- Insights into origins and specificities of autoantibodies in systemic sclerosis
- (2021) Eleni Tiniakou et al. CURRENT OPINION IN RHEUMATOLOGY
- Autoantibody profiles delineate distinct subsets of scleromyositis
- (2021) Valérie Leclair et al. RHEUMATOLOGY
- Anti‐centromere antibody levels and isotypes and the development of systemic sclerosis
- (2021) Nina M. van Leeuwen et al. Arthritis & Rheumatology
- Nintedanib in patients with systemic sclerosis‐associated interstitial lung disease: subgroup analyses by autoantibody status and skin score
- (2021) Masataka Kuwana et al. Arthritis & Rheumatology
- Quantification of Antifibrillarin (anti-U3 RNP) Antibodies: A New Insight for Patients with Systemic Sclerosis
- (2021) Audrey Benyamine et al. Diagnostics
- Systemic Sclerosis-Associated Pulmonary Hypertension: Spectrum and Impact
- (2021) Mario Naranjo et al. Diagnostics
- Lung ultrasound B-lines in systemic sclerosis: cut-off values and methodological indications for interstitial lung disease screening
- (2021) Luna Gargani et al. RHEUMATOLOGY
- Association between autoantibodies in systemic sclerosis and cancer in a national registry
- (2021) Sabrina Hoa et al. RHEUMATOLOGY
- Riociguat in patients with early diffuse cutaneous systemic sclerosis (RISE-SSc): randomised, double-blind, placebo-controlled multicentre trial
- (2020) Dinesh Khanna et al. ANNALS OF THE RHEUMATIC DISEASES
- Anti-Ku Antibody-Related Scleroderma-Polymyositis Overlap Syndrome Associated With Hypothyroid Myopathy
- (2020) Yuji Kadowaki et al. JCR-JOURNAL OF CLINICAL RHEUMATOLOGY
- Clinical features of Japanese systemic sclerosis (SSc) patients negative for SSc‐related autoantibodies: A single‐center retrospective study
- (2020) Miho Miyake et al. International Journal of Rheumatic Diseases
- A study of antigen-specific anti-cytomegalovirus antibody reactivity in patients with systemic sclerosis and concomitant anti-Ro52 antibodies
- (2020) Athanasios Gkoutzourelas et al. RHEUMATOLOGY INTERNATIONAL
- Gastric Antral Vascular Ectasia in Systemic Sclerosis: Association with Anti-RNA Polymerase III and Negative Anti-Nuclear Antibodies
- (2020) Naomi Serling-Boyd et al. SEMINARS IN ARTHRITIS AND RHEUMATISM
- Genomic Risk Score impact on susceptibility to systemic sclerosis
- (2020) Lara Bossini-Castillo et al. ANNALS OF THE RHEUMATIC DISEASES
- Progressive interstitial lung disease in patients with systemic sclerosis-associated interstitial lung disease in the EUSTAR database
- (2020) Anna-Maria Hoffmann-Vold et al. ANNALS OF THE RHEUMATIC DISEASES
- Association of differentially expressed genes and autoantibody type in patients with systemic sclerosis
- (2020) Jun Inamo RHEUMATOLOGY
- Tocilizumab in systemic sclerosis: a randomised, double-blind, placebo-controlled, phase 3 trial
- (2020) Dinesh Khanna et al. Lancet Respiratory Medicine
- The prevalence and incidence rate of pulmonary arterial hypertension in systemic sclerosis: Systematic review and meta-analysis
- (2020) Manuel Rubio-Rivas et al. AUTOIMMUNITY REVIEWS
- Anti-PM/Scl Antibody-positive Systemic Sclerosis Complicated by Multiple Organ Involvement
- (2020) Tatsuya Shimizu et al. INTERNAL MEDICINE
- Intriguing Relationships Between Cancer and Systemic Sclerosis: Role of the Immune System and Other Contributors
- (2019) Alexandre Thibault Jacques Maria et al. Frontiers in Immunology
- Progressive skin fibrosis is associated with a decline in lung function and worse survival in patients with diffuse cutaneous systemic sclerosis in the European Scleroderma Trials and Research (EUSTAR) cohort
- (2019) Wanlong Wu et al. ANNALS OF THE RHEUMATIC DISEASES
- A comprehensive analysis of antigen-specific antibody responses against human cytomegalovirus in patients with systemic sclerosis
- (2019) Georgios Efthymiou et al. CLINICAL IMMUNOLOGY
- GWAS for systemic sclerosis identifies multiple risk loci and highlights fibrotic and vasculopathy pathways
- (2019) Elena López-Isac et al. Nature Communications
- Using autoantibodies and cutaneous subset to develop outcome‐based disease classification in systemic sclerosis
- (2019) Svetlana I. Nihtyanova et al. Arthritis & Rheumatology
- HLAand autoantibodies define scleroderma subtypes and risk in African and European Americans and suggest a role for molecular mimicry
- (2019) Pravitt Gourh et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- An update on autoantibodies in scleroderma
- (2018) Christopher A. Mecoli et al. CURRENT OPINION IN RHEUMATOLOGY
- Prevalence of auto-antibodies associated to pulmonary arterial hypertension in scleroderma – A review
- (2018) José Pedro L. Nunes et al. AUTOIMMUNITY REVIEWS
- Performance of Anti–Topoisomerase I Antibody Testing by Multiple-Bead, Enzyme-Linked Immunosorbent Assay and Immunodiffusion in a University Setting
- (2018) Kate LaRiviere Homer et al. JCR-JOURNAL OF CLINICAL RHEUMATOLOGY
- Malignancies in Patients with Anti-RNA Polymerase III Antibodies and Systemic Sclerosis: Analysis of the EULAR Scleroderma Trials and Research Cohort and Possible Recommendations for Screening
- (2017) Maria-Grazia Lazzaroni et al. JOURNAL OF RHEUMATOLOGY
- Systemic sclerosis
- (2017) Christopher P Denton et al. LANCET
- Presence of anti-eukaryotic initiation factor-2B, anti-RuvBL1/2 and anti-synthetase antibodies in patients with anti-nuclear antibody negative systemic sclerosis
- (2017) John D Pauling et al. RHEUMATOLOGY
- There is a need for new systemic sclerosis subset criteria. A content analytic approach
- (2017) SR Johnson et al. SCANDINAVIAN JOURNAL OF RHEUMATOLOGY
- Association of Fibrosing Myopathy in Systemic Sclerosis and Higher Mortality
- (2017) Julie J. Paik et al. ARTHRITIS CARE & RESEARCH
- Characteristics and Survival of Anti-U1 RNP Antibody-Positive Patients With Connective Tissue Disease-Associated Pulmonary Arterial Hypertension
- (2016) Vincent Sobanski et al. Arthritis & Rheumatology
- Brief Report: Anti-Eukaryotic Initiation Factor 2B Autoantibodies Are Associated With Interstitial Lung Disease in Patients With Systemic Sclerosis
- (2016) Zoe E. Betteridge et al. Arthritis & Rheumatology
- Evidence-based detection of pulmonary arterial hypertension in systemic sclerosis: the DETECT study
- (2013) J Gerry Coghlan et al. ANNALS OF THE RHEUMATIC DISEASES
- Gastric Antral Vascular Ectasia and Its Clinical Correlates in Patients with Early Diffuse Systemic Sclerosis in the SCOT Trial
- (2013) E. W. Hung et al. JOURNAL OF RHEUMATOLOGY
- Anti-Fibrillarin Antibody in African American Patients with Systemic Sclerosis: Immunogenetics, Clinical Features, and Survival Analysis
- (2011) R. SHARIF et al. JOURNAL OF RHEUMATOLOGY
- Prevalence and clinical associations of anti-Ku antibodies in systemic autoimmune diseases
- (2008) I Cavazzana et al. LUPUS
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started